 This is an observational, prospective, open-label, single-arm, multicenter, real-life study designed to observe the impact of paritaprevirritonavirombitasvir with dasabuvir regimen ViekiraxExviera, 3D regimen on total daytime physical activity and fatigue in participants with Hepatitis C Virus HCV genotype 1 GT1. 